CENTENE CORPORATION Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
CENTENE CORPORATION (CNC) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-02-17
- CENTENE CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- CENTENE CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was $6.00M, a 200.00% increase year-over-year.
- CENTENE CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was $2.00M, a 93.94% decline year-over-year.
- CENTENE CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2022-03-31 was $33.00M.
- CENTENE CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CENTENE CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was $8.00M.
- CENTENE CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was -$32.00M.
- CENTENE CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$11.00M.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-17 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-10-29 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-07-25 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-04-25 | |||
| 2024-12-31 | $8.00M 10-K · filed 2026-02-17 | |||
| 2024-09-30 | $7.00M 10-Q · filed 2025-10-29 | |||
| 2024-06-30 | $7.00M 10-Q · filed 2025-07-25 | |||
| 2024-03-31 | $6.00M 10-Q · filed 2025-04-25 | |||
| 2023-12-31 | -$32.00M 10-K · filed 2026-02-17 | |||
| 2023-09-30 | $19.00M 10-Q · filed 2024-10-25 | |||
| 2023-06-30 | -$7.00M 10-Q · filed 2024-07-26 | |||
| 2023-03-31 | $2.00M 10-Q · filed 2024-04-26 | |||
| 2022-12-31 | -$11.00M 10-K · filed 2025-02-18 | |||
| 2022-09-30 | -$37.00M 10-Q · filed 2023-10-24 | |||
| 2022-06-30 | -$9.00M 10-Q · filed 2023-07-28 | |||
| 2022-03-31 | $33.00M 10-Q · filed 2023-04-25 | |||
| 2021-12-31 | -$11.00M 10-K · filed 2024-02-20 | |||
| 2021-09-30 | -$8.00M 10-Q · filed 2022-10-25 | |||
| 2021-06-30 | -$24.00M 10-Q · filed 2022-07-26 | |||
| 2021-03-31 | -$16.00M 10-Q · filed 2022-04-26 | |||
| 2020-12-31 | $18.00M 10-K · filed 2023-02-21 | |||
| 2020-09-30 | $8.00M 10-Q · filed 2021-10-26 | |||
| 2020-06-30 | $3.00M 10-Q · filed 2021-07-27 | |||
| 2020-03-31 | -$1.00M 10-Q · filed 2021-04-27 | |||
| 2019-12-31 | -$2.00M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | $4.00M 10-Q · filed 2020-10-27 | |||
| 2019-06-30 | $2.00M 10-Q · filed 2020-07-28 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-04-28 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-22 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-10-22 | |||
| 2018-06-30 | $0.00 10-Q · filed 2019-07-23 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-18 | |||
| 2016-12-31 | -$1.00M 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |